Castle Biosciences (CSTL) Stock Forecast for 2024–2028. Sell or Buy Prediction







6 Best Growth Stocks To Buy Now According to Metatrader 5

March 15, 2024 6 Best Growth Stocks To Buy Now According to Metatrader 5

One of the reasons investors prefer growth stocks is that they are expected to perform better than other companies in terms of sales…
Navigating GBP Forecast: Mistakes To Avoid In Forex Trading

March 6, 2024 Navigating GBP Forecast: Mistakes To Avoid In Forex Trading

Human error is common in forex trading and often leads to familiar trading issues. These trading mishaps lead to significant novice traders regularly. …
Trading Penny Stocks for Profit: Expert Insights and Practical Advice

February 22, 2024 Trading Penny Stocks for Profit: Expert Insights and Practical Advice

For aspiring traders and seasoned investors alike, the enticing appeal of penny stocks can be likened to voyaging across the vast oceans, discovering…
Getting A Kredittkort Norge Approval Isn’t Difficult

February 8, 2024 Getting A Kredittkort Norge Approval Isn’t Difficult

If you meet the conditions, you can open an account for checking in Norway. However, it will be much easier and more convenient…

Castle Biosciences (CSTL) Stock Forecast for 2024–2028. Sell or Buy?

Updated: March 18, 2024 (11:32)

Sector: Healthcare

The share price of Castle Biosciences, Inc. (CSTL) now

Latest session on the 18th of March for
Castle Biosciences, Inc. is positive
Trading Volume: 175450
Open: 18.85 /  High: 19.28 /  Low: 18.63
What analysts predict: $33.11
52-week High/Low: $26.7 / $9.26

50/200 Day Moving Average: $22.06 / $18.46

This figure corresponds to the Average Price over the previous 50/200 days. For Castle Biosciences stocks, the 50-day moving average is the resistance level today.

For Castle Biosciences stocks, the 200-day moving average is the support level today.

Are you interested in Castle Biosciences, Inc. stocks and want to buy them, or are they already in your portfolio? If yes, then on this page you will find useful information about the dynamics of the Castle Biosciences stock price in 2024, 2025, 2026, 2027, 2028. How much will one Castle Biosciences share be worth in 2024 - 2028?

When should I take profit in Castle Biosciences stock? When should I record a loss on Castle Biosciences stock? What are analysts' forecasts for Castle Biosciences stock? What is the future of Castle Biosciences stock? We forecast Castle Biosciences stock performance using neural networks based on historical data on Castle Biosciences stocks. Also, when forecasting, technical analysis tools are used, world geopolitical and news factors are taken into account.

Castle Biosciences stock prediction results are shown below and presented in the form of graphs, tables and text information, divided into time intervals. (Next month, 2024, 2025, 2026, 2027 and 2028) The final quotes of the instrument at the close of the previous trading day are a signal to adjust the forecasts for Castle Biosciences shares. This happens once a day.


Historical and forecast chart of Castle Biosciences stock

The chart below shows the historical price of Castle Biosciences stock and a prediction chart for the next month. For convenience, prices are divided by color. Forecast prices include: Optimistic Forecast, Pessimistic Forecast, and Weighted Average Best Forecast. Detailed values for the Castle Biosciences stock price can be found in the table below.

Long-term forecasts by years.

Castle of Biological Sciences, Inc., a commercial stage dermatological cancer, develops and commercializes diagnostic and prognostic tests for cancers. Its flagship product is DecisionDx-Melanoma, a Multiple Gene Expression Profile (GEP) test for identifying Stage I and II patients at high risk of metastasis, based on biological information from 31 genes in their tumor tissue. The company also offers the DecisionDx-UM test, a proprietary GEP test that predicts the risk of metastasis in patients with uveal melanoma, a rare eye cancer; and two late-stage proprietary products that address squamous cell skin cancer and suspicious pigmented lesions, which are highly clinical indications for dermatological cancer. It offers testing services through physicians, physician assistants and nurse practitioners. The company was founded in 2007 and is headquartered in Friendswood, Texas.

Castle Biosciences daily forecast for a month

Date Target Pes. Opt. Vol., %
Feb 22 19.76 19.19 20.39 6.26
Feb 23 20.13 19.96 20.39 2.18
Feb 24 19.40 18.84 19.63 4.20
Feb 25 19.03 18.72 19.28 2.97
Feb 26 18.97 18.40 19.48 5.86
Feb 27 18.67 18.28 19.04 4.13
Feb 28 18.45 18.12 18.65 2.93
Feb 29 18.17 17.78 18.52 4.13
Mar 01 18.07 17.87 18.28 2.31
Mar 02 17.76 17.36 18.13 4.46
Mar 03 17.82 17.40 18.17 4.42
Mar 04 18.27 17.78 18.65 4.89
Mar 05 18.77 18.40 19.17 4.16
Mar 06 19.07 18.47 19.24 4.17
Mar 07 19.39 18.91 19.89 5.17
Mar 08 19.43 18.96 19.79 4.39
Mar 09 19.78 19.39 20.24 4.41
Mar 10 19.99 19.83 20.59 3.87
Mar 11 19.25 18.73 19.86 6.00
Mar 12 18.98 18.61 19.38 4.12
Mar 13 19.01 18.75 19.47 3.81
Mar 14 18.56 18.00 19.12 6.23
Mar 15 18.62 18.13 19.14 5.59
Mar 16 18.75 18.16 19.33 6.44
Mar 17 19.09 18.64 19.61 5.20
Mar 18 19.03 18.49 19.39 4.86
Mar 19 18.33 17.94 18.54 3.31
Mar 20 18.55 18.13 18.73 3.32
Mar 21 18.56 18.19 19.06 4.78
Mar 22 18.13 17.61 18.47 4.86

Castle Biosciences Daily Price Targets


Castle Biosciences Stock Forecast 02-22-2024.

Forecast target price for 02-22-2024: $19.76.
Positive dynamics for Castle Biosciences shares will prevail with possible volatility of 5.891%.
Pessimistic target level: 19.19
Optimistic target level: 20.39

Castle Biosciences Stock Forecast 02-23-2024.

Forecast target price for 02-23-2024: $20.13.
Positive dynamics for Castle Biosciences shares will prevail with possible volatility of 2.132%.
Pessimistic target level: 19.96
Optimistic target level: 20.39

Castle Biosciences Stock Forecast 02-24-2024.

Forecast target price for 02-24-2024: $19.40.
Negative dynamics for Castle Biosciences shares will prevail with possible volatility of 4.031%.
Pessimistic target level: 18.84
Optimistic target level: 19.63

Castle Biosciences Stock Forecast 02-25-2024.

Forecast target price for 02-25-2024: $19.03.
Negative dynamics for Castle Biosciences shares will prevail with possible volatility of 2.882%.
Pessimistic target level: 18.72
Optimistic target level: 19.28

Castle Biosciences Stock Forecast 02-26-2024.

Forecast target price for 02-26-2024: $18.97.
Negative dynamics for Castle Biosciences shares will prevail with possible volatility of 5.534%.
Pessimistic target level: 18.40
Optimistic target level: 19.48

Castle Biosciences Stock Forecast 02-27-2024.

Forecast target price for 02-27-2024: $18.67.
Negative dynamics for Castle Biosciences shares will prevail with possible volatility of 3.962%.
Pessimistic target level: 18.28
Optimistic target level: 19.04

CSTL (CSTL) Monthly Stock Prediction for 2024

Month Target Pes. Opt. Vol., %
Apr. 21.73 19.85 23.19 14.43
May. 22.16 21.35 24.15 11.56
Jun. 23.00 20.87 24.29 14.05
Jul. 21.07 19.86 23.31 14.80
Aug. 22.54 20.20 24.15 16.33
Sep. 22.10 19.96 23.68 15.68
Oct. 23.71 22.41 25.43 11.88
Nov. 23.14 22.14 24.86 10.95
Dec. 21.98 20.81 23.79 12.54

Castle Biosciences forecast for this year


Castle Biosciences Stock Prediction for Apr 2024

An uptrend is forecast for this month with an optimal target price of $21.7336. Pessimistic: $19.85. Optimistic: $23.19


Castle Biosciences Stock Prediction for May 2024

An uptrend is forecast for this month with an optimal target price of $22.1595. Pessimistic: $21.35. Optimistic: $24.15


Castle Biosciences Stock Prediction for Jun 2024

An uptrend is forecast for this month with an optimal target price of $22.9972. Pessimistic: $20.87. Optimistic: $24.29


Castle Biosciences Stock Prediction for Jul 2024

An downtrend is forecast for this month with an optimal target price of $21.0654. Pessimistic: $19.86. Optimistic: $23.31


Castle Biosciences Stock Prediction for Aug 2024

An uptrend is forecast for this month with an optimal target price of $22.54. Pessimistic: $20.20. Optimistic: $24.15


Castle Biosciences Stock Prediction for Sep 2024

An downtrend is forecast for this month with an optimal target price of $22.0982. Pessimistic: $19.96. Optimistic: $23.68


Castle Biosciences Stock Prediction for Oct 2024

An uptrend is forecast for this month with an optimal target price of $23.707. Pessimistic: $22.41. Optimistic: $25.43


Castle Biosciences Stock Prediction for Nov 2024

An downtrend is forecast for this month with an optimal target price of $23.1427. Pessimistic: $22.14. Optimistic: $24.86


Castle Biosciences Stock Prediction for Dec 2024

An downtrend is forecast for this month with an optimal target price of $21.9763. Pessimistic: $20.81. Optimistic: $23.79



Castle Biosciences (CSTL) Monthly Stock Prediction for 2025

Month Target Pes. Opt. Vol., %
Jan 19.73 18.96 20.59 7.92
Feb 17.22 15.53 17.70 12.26
Mar 17.02 16.21 18.93 14.35
Apr 18.43 16.86 20.31 17.02
May 19.28 17.53 21.28 17.63
Jun 20.71 19.61 22.71 13.66
Jul 23.03 20.55 24.48 16.07
Aug 23.23 20.66 24.14 14.42
Sep 24.04 23.23 25.62 9.33
Oct 26.76 23.95 29.35 18.38
Nov 28.04 25.45 29.80 14.62
Dec 26.27 23.84 28.48 16.27

Castle Biosciences (CSTL) Monthly Stock Prediction for 2026

Month Target Pes. Opt. Vol., %
Jan 26.12 24.55 28.03 12.40
Feb 24.33 23.58 26.99 12.62
Mar 23.82 22.02 25.12 12.35
Apr 24.92 22.41 27.16 17.47
May 27.16 25.67 29.25 12.22
Jun 30.12 28.56 31.43 9.12
Jul 31.26 27.89 33.88 17.69
Aug 29.81 26.68 33.15 19.51
Sep 25.93 23.79 28.73 17.19
Oct 27.64 26.52 30.23 12.29
Nov 29.19 27.72 31.60 12.29
Dec 29.11 27.35 32.20 15.06

Castle Biosciences (CSTL) Monthly Stock Prediction for 2027

Month Target Pes. Opt. Vol., %
Jan 32.57 30.88 33.85 8.76
Feb 32.52 31.11 35.98 13.54
Mar 36.99 33.00 39.78 17.05
Apr 36.99 35.90 40.66 11.72
May 41.34 39.31 43.65 9.94
Jun 39.89 35.42 42.57 16.79
Jul 41.17 37.37 44.98 16.92
Aug 41.63 38.08 46.01 17.23
Sep 41.93 39.87 46.56 14.37
Oct 40.16 38.08 43.14 11.73
Nov 40.33 35.82 41.69 14.09
Dec 45.87 43.94 49.91 11.96

Castle Biosciences (CSTL) Monthly Stock Prediction for 2028

Month Target Pes. Opt. Vol., %
Jan 51.84 48.28 53.58 9.89
Feb 57.72 55.70 63.70 12.56
Mar 55.78 52.97 61.63 14.06
Apr 60.70 56.19 63.16 11.03
May 68.35 63.75 74.37 14.28
Jun 65.76 63.18 70.00 9.73
Jul 63.92 59.98 66.70 10.06
Aug 66.70 63.15 71.74 11.97
Sep 58.66 55.87 63.76 12.37
Oct 54.72 49.74 60.47 17.74
Nov 51.89 47.53 56.83 16.36
Dec 55.16 50.60 57.16 11.48

Castle Biosciences information and performance

Castle Biosciences Address

820 S FRIENDSWOOD DRIVE, SUITE 201, FRIENDSWOOD, TX, US

Market Capitalization: 545 157 000 $

Market capitalization of the Castle Biosciences, Inc. is the total market value of all issued shares of a company. It is calculated by the formula multiplying the number of CSTL shares in the company outstanding by the market price of one share.

EBITDA: -55 647 000 $

EBITDA of Castle Biosciences is earnings before interest, income tax and depreciation of assets.

PE Ratio: None

P/E ratio (price to earnings) - shows the ratio between the price of a share and the company's profit

PEG Ratio: None

Price/earnings to growth

DPS: None

Dividend Per Share is a financial indicator equal to the ratio of the company's net profit available for distribution to the annual average of ordinary shares.

DY: None

Dividend yield is a ratio that shows how much a company pays in dividends each year at the stock price.

EPS: -2.14

EPS shows how much of the net profit is accounted for by the common share.

Quarterly Earnings Growth YOY: -0.926
Quarterly Revenue Growth YOY: 0.725
Trailing PE: -

Trailing P/E depends on what has already been done. It uses the current share price and divides it by the total earnings per share for the last 12 months.

Forward PE: -

Forward P/E uses projections of future earnings instead of final numbers.

EV To Revenue: 1.443

Enterprise Value (EV) /Revenue

EV To EBITDA: -7.04

The EV / EBITDA ratio shows the ratio of the cost (EV) to its profit before tax, interest and amortization (EBITDA).

Shares Outstanding: 27450000

Number of issued ordinary shares

Shares Float: N/A

Number of freely tradable shares

Shares Short Prior Month: N/A

Shares Short Prior Month - the number of shares in short positions in the last month.

Short Ratio: N/A
Percent Insiders: N/A
Percent Institutions: N/A



Related stocks from Healthcare sector


Disclaimer:

All forecast data on the site are provided for informational purposes of using neural forecasting tools in the financial market and are not a call to action and, moreover, are not trading signals. When using the forecast data, the investor assumes all financial risks. The pandaforecast.com portal is not responsible for the loss of your money in the stock market as a result of using the information contained on the site.